<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32175624</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2075</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>The EMBO journal</Title><ISOAbbreviation>EMBO J</ISOAbbreviation></Journal><ArticleTitle>Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS/FTD.</ArticleTitle><Pagination><StartPage>e102811</StartPage><MedlinePgn>e102811</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e102811</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embj.2019102811</ELocationID><Abstract><AbstractText>The C9orf72 repeat expansion causes amyotrophic lateral sclerosis and frontotemporal dementia, but the poor correlation between C9orf72-specific pathology and TDP-43 pathology linked to neurodegeneration hinders targeted therapeutic development. Here, we addressed the role of the aggregating dipeptide repeat proteins resulting from unconventional translation of the repeat in all reading frames. Poly-GA promoted cytoplasmic mislocalization and aggregation of TDP-43 non-cell-autonomously, and anti-GA antibodies ameliorated TDP-43 mislocalization in both donor and receiver cells. Cell-to-cell transmission of poly-GA inhibited proteasome function in neighboring cells. Importantly, proteasome inhibition led to the accumulation of TDP-43 ubiquitinated within the nuclear localization signal (NLS) at lysine 95. Mutagenesis of this ubiquitination site completely blocked poly-GA-dependent mislocalization of TDP-43. Boosting proteasome function with rolipram reduced both poly-GA and TDP-43 aggregation. Our data from cell lines, primary neurons, transgenic mice, and patient tissue suggest that poly-GA promotes TDP-43 aggregation by inhibiting the proteasome cell-autonomously and non-cell-autonomously, which can be prevented by inhibiting poly-GA transmission with antibodies or boosting proteasome activity with rolipram.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Published under the terms of the CC BY NC ND 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khosravi</LastName><ForeName>Bahram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Systemic Neurosciences (GSN), Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>LaClair</LastName><ForeName>Kathrine D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Riemenschneider</LastName><ForeName>Henrick</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Qihui</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0001-5733-9820</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frottin</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, Martinsried, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mareljic</LastName><ForeName>Nikola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czuppa</LastName><ForeName>Mareike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farny</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartmann</LastName><ForeName>Hannelore</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michaelsen</LastName><ForeName>Meike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arzberger</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartl</LastName><ForeName>F Ulrich</ForeName><Initials>FU</Initials><Identifier Source="ORCID">0000-0002-7941-135X</Identifier><AffiliationInfo><Affiliation>Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, Martinsried, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hipp</LastName><ForeName>Mark S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-0497-3016</Identifier><AffiliationInfo><Affiliation>Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, Martinsried, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences of Cells and Systems, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edbauer</LastName><ForeName>Dieter</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7186-4653</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Systemic Neurosciences (GSN), Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>NOMIS Stiftung (NOMIS Foundation)</Agency><Country>International</Country></Grant><Grant><GrantID>617198</GrantID><Agency>EC | Seventh Framework Programme (FP7)</Agency><Country>International</Country></Grant><Grant><GrantID>EXC 2145</GrantID><Agency>Deutsche Forschungsgemeinschaft (DFG)</Agency><Country>International</Country></Grant><Grant><Agency>Hans und Ilse Breuer Foundation</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO J</MedlineTA><NlmUniqueID>8208664</NlmUniqueID><ISSNLinking>0261-4189</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019913">Nuclear Localization Signals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>926-77-2</RegistryNumber><NameOfSubstance UI="C065992">N-glycylalanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019913" MajorTopicYN="N">Nuclear Localization Signals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">
C9orf72
</Keyword><Keyword MajorTopicYN="N">antibody therapy</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">nucleocytoplasmic transport</Keyword><Keyword MajorTopicYN="N">proteasome</Keyword></KeywordList><CoiStatement>D.E. holds a patent on &#x201c;Dipeptide&#x2010;repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion&#x201d; (EP2948777 and US10066007).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32175624</ArticleId><ArticleId IdType="pmc">PMC7156967</ArticleId><ArticleId IdType="doi">10.15252/embj.2019102811</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akimov V, Barrio&#x2010;Hernandez I, Hansen SVF, Hallenborg P, Pedersen AK, Bekker&#x2010;Jensen DB, Puglia M, Christensen SDK, Vanselow JT, Nielsen MM et&#xa0;al (2018) UbiSite approach for comprehensive mapping of lysine and N&#x2010;terminal ubiquitination sites. Nat Struct Mol Biol 25: 631&#x2013;640</Citation><ArticleIdList><ArticleId IdType="pubmed">29967540</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksu M, Pleiner T, Karaca S, Kappert C, Dehne HJ, Seibel K, Urlaub H, Bohnsack MT, Gorlich D (2018) Xpo7 is a broad&#x2010;spectrum exportin and a nuclear import receptor. J Cell Biol 217: 2329&#x2013;2340</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6028547</ArticleId><ArticleId IdType="pubmed">29748336</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold HC, Jackson KL, Arora A, Weskamp K, Tank EM, Li X, Miguez R, Dayton RD, Tamir S, Klein RL et&#xa0;al (2018) TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci Rep 8: 4606</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Michiels E, Gijselinck I, Sieben A, Jovicic A, De Baets G, Scheveneels W, Steyaert J, Cuijt I et&#xa0;al (2016) Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci Rep 6: 20877</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Kovacs D, Konijnenberg A, Timmerman E, Volkov A, Guharoy M, De Decker M, Jaspers T, Ryan VH et&#xa0;al (2017) Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol Cell 65: 1044&#x2013;1055.e1045</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YJ, Jeng US, Chiang YL, Hwang IS, Chen YR (2016) The glycine&#x2010;alanine dipeptide repeat from C9orf72 hexanucleotide expansions forms toxic amyloids possessing cell&#x2010;to&#x2010;cell transmission properties. J Biol Chem 291: 4903&#x2013;4911</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4777828</ArticleId><ArticleId IdType="pubmed">26769963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen BB, Mallampalli RK (2009) Masking of a nuclear signal motif by monoubiquitination leads to mislocalization and degradation of the regulatory enzyme cytidylyltransferase. Mol Cell Biol 29: 3062&#x2013;3075</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682000</ArticleId><ArticleId IdType="pubmed">19332566</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Gendron TF, Prudencio M, Sasaguri H, Zhang YJ, Castanedes&#x2010;Casey M, Lee CW, Jansen&#x2010;West K, Kurti A, Murray ME et&#xa0;al (2015) Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP&#x2010;43 pathology, neuronal loss, and behavioral deficits. Science 348: 1151&#x2013;1154</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, Zhang Y, Umoh ME, Vaughan SW, Lorenzini I, Liu F, Sayegh M, Donlin&#x2010;Asp PG, Chen YH, Duong DM et&#xa0;al (2018) TDP&#x2010;43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci 21: 228&#x2013;239</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG (2000) Short&#x2010;lived green fluorescent proteins for quantifying ubiquitin/proteasome&#x2010;dependent proteolysis in living cells. Nat Biotechnol 18: 538&#x2013;543</Citation><ArticleIdList><ArticleId IdType="pubmed">10802622</ArticleId></ArticleIdList></Reference><Reference><Citation>De Smet F, Saiz Rubio M, Hompes D, Naus E, De Baets G, Langenberg T, Hipp MS, Houben B, Claes F, Charbonneau S et&#xa0;al (2017) Nuclear inclusion bodies of mutant and wild&#x2010;type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation. J Pathol 242: 24&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pubmed">28035683</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus&#x2010;Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J et&#xa0;al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p&#x2010;linked FTD and ALS. Neuron 72: 245&#x2013;256</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus&#x2010;Hernandez M, Finch NA, Wang X, Gendron TF, Bieniek KF, Heckman MG, Vasilevich A, Murray ME, Rousseau L, Weesner R et&#xa0;al (2017) In&#x2010;depth clinico&#x2010;pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers. Acta Neuropathol 134: 255&#x2013;269</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5508036</ArticleId><ArticleId IdType="pubmed">28508101</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer D, Haass C (2016) An amyloid&#x2010;like cascade hypothesis for C9orf72 ALS/FTD. Curr Opin Neurobiol 36: 99&#x2013;106</Citation><ArticleIdList><ArticleId IdType="pubmed">26555807</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H, Dormann D (2017) TDP&#x2010;43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett 591: 1489&#x2013;1507</Citation><ArticleIdList><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H, Funk C, Abou&#x2010;Ajram C, Hutten S, Funk EBE, Kehlenbach RH, Bailer SM, Dormann D (2018) Nuclear egress of TDP&#x2010;43 and FUS occurs independently of exportin&#x2010;1/CRM1. Sci Rep 8: 7084</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935713</ArticleId><ArticleId IdType="pubmed">29728564</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eersel J, Ke YD, Gladbach A, Bi M, Gotz J, Kril JJ, Ittner LM (2011) Cytoplasmic accumulation and aggregation of TDP&#x2010;43 upon proteasome inhibition in cultured neurons. PLoS ONE 6: e22850</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146516</ArticleId><ArticleId IdType="pubmed">21829535</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores BN, Dulchavsky ME, Krans A, Sawaya MR, Paulson HL, Todd PK, Barmada SJ, Ivanova MI (2016) Distinct C9orf72&#x2010;associated dipeptide repeat structures correlate with neuronal toxicity. PLoS ONE 11: e0165084</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5077081</ArticleId><ArticleId IdType="pubmed">27776165</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez&#x2010;Gonzalez R, Kim NC, Almeida S, Lee KH, Badders N, Valentine M, Miller BL, Wong PC et&#xa0;al (2015) GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525: 129&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick P, Sellier C, Mackenzie IRA, Cheng CY, Tahraoui&#x2010;Bories J, Martinat C, Pasterkamp RJ, Prudlo J, Edbauer D, Oulad&#x2010;Abdelghani M et&#xa0;al (2018) Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol Commun 6: 72</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091050</ArticleId><ArticleId IdType="pubmed">30075745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao FB, Almeida S, Lopez&#x2010;Gonzalez R (2017) Dysregulated molecular pathways in amyotrophic lateral sclerosis&#x2010;frontotemporal dementia spectrum disorder. EMBO J 36: 2931&#x2013;2950</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Petrucelli L (2011) Rodent models of TDP&#x2010;43 proteinopathy: investigating the mechanisms of TDP&#x2010;43&#x2010;mediated neurodegeneration. J Mol Neurosci 45: 486&#x2013;499</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207125</ArticleId><ArticleId IdType="pubmed">21811811</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, Martinez&#x2010;Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, Xie SX, Kwong LK, Elman L, McCluskey L et&#xa0;al (2009) Clinical and pathological continuum of multisystem TDP&#x2010;43 proteinopathies. Arch Neurol 66: 180&#x2013;189</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2774117</ArticleId><ArticleId IdType="pubmed">19204154</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotzl JK, Lang CM, Haass C, Capell A (2016) Impaired protein degradation in FTLD and related disorders. Ageing Res Rev 32: 122&#x2013;139</Citation><ArticleIdList><ArticleId IdType="pubmed">27166223</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Kim HJ, Wang H, Monaghan J, Freyermuth F, Sung JC, O'Donovan K, Fare CM, Diaz Z, Singh N et&#xa0;al (2018a) Nuclear&#x2010;import receptors reverse aberrant phase transitions of RNA&#x2010;binding proteins with prion&#x2010;like domains. Cell 173: 677&#x2013;692.e620</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Lehmer C, Martinez&#x2010;Sanchez A, Rudack T, Beck F, Hartmann H, Perez&#x2010;Berlanga M, Frottin F, Hipp MS, Hartl FU et&#xa0;al (2018b) In situ structure of neuronal C9orf72 poly&#x2010;GA aggregates reveals proteasome recruitment. Cell 172: 696&#x2013;705.e612</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6035389</ArticleId><ArticleId IdType="pubmed">29398115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F, Eckert M, von Zweydorf F, Gloeckner CJ, Kahle PJ (2018) Identification and characterization of ubiquitinylation sites in TAR DNA&#x2010;binding protein of 43&#xa0;kDa (TDP&#x2010;43). J Biol Chem 293: 16083&#x2013;16099</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6187624</ArticleId><ArticleId IdType="pubmed">30120199</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, Hutten S, Bourgeois B, Spreitzer E, Niedner&#x2010;Boblenz A, Schifferer M, Ruepp MD, Simons M, Niessing D, Madl T et&#xa0;al (2018) Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell 173: 706&#x2013;719.e713</Citation><ArticleIdList><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, Kwong LK, Chen&#x2010;Plotkin A, Winton MJ, Unger TL, Xu Y, Neumann M, Trojanowski JQ, Lee VM (2009) Expression of TDP&#x2010;43 C&#x2010;terminal fragments in&#xa0;vitro recapitulates pathological features of TDP&#x2010;43 proteinopathies. J Biol Chem 284: 8516&#x2013;8524</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2659210</ArticleId><ArticleId IdType="pubmed">19164285</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic A, Mertens J, Boeynaems S, Bogaert E, Chai N, Yamada SB, Paul JW 3rd, Sun S, Herdy JR, Bieri G et&#xa0;al (2015) Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci 18: 1226&#x2013;1229</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M, Walker LC (2018) Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat Neurosci 21: 1341&#x2013;1349</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6375686</ArticleId><ArticleId IdType="pubmed">30258241</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi B, Hartmann H, May S, Mohl C, Ederle H, Michaelsen M, Schludi MH, Dormann D, Edbauer D (2017) Cytoplasmic poly&#x2010;GA aggregates impair nuclear import of TDP&#x2010;43 in C9orf72 ALS/FTLD. Hum Mol Genet 26: 790&#x2013;800</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409121</ArticleId><ArticleId IdType="pubmed">28040728</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ et&#xa0;al (2011) Systematic and quantitative assessment of the ubiquitin&#x2010;modified proteome. Mol Cell 44: 325&#x2013;340</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200427</ArticleId><ArticleId IdType="pubmed">21906983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraut DA (2013) Slippery substrates impair ATP&#x2010;dependent protease function by slowing unfolding. J Biol Chem 288: 34729&#x2013;34735</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3843084</ArticleId><ArticleId IdType="pubmed">24151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YB, Baskaran P, Gomez&#x2010;Deza J, Chen HJ, Nishimura AL, Smith BN, Troakes C, Adachi Y, Stepto A, Petrucelli L et&#xa0;al (2017) C9orf72 poly GA RAN&#x2010;translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity. Hum Mol Genet 26: 4765&#x2013;4777</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886201</ArticleId><ArticleId IdType="pubmed">28973350</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG (1997) Inhibition of ubiquitin/proteasome&#x2010;dependent protein degradation by the Gly&#x2010;Ala repeat domain of the Epstein&#x2010;Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 94: 12616&#x2013;12621</Citation><ArticleIdList><ArticleId IdType="pmc">PMC25057</ArticleId><ArticleId IdType="pubmed">9356498</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79: 416&#x2013;438</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pattamatta A, Zu T, Reid T, Bardhi O, Borchelt DR, Yachnis AT, Ranum LP (2016) C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron 90: 521&#x2013;534</Citation><ArticleIdList><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokireddy S, Kukushkin NV, Goldberg AL (2015) cAMP&#x2010;induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins. Proc Natl Acad Sci USA 112: E7176&#x2013;E7185</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702992</ArticleId><ArticleId IdType="pubmed">26669444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumpkin RJ, Gu H, Zhu Y, Leonard M, Ahmad AS, Clauser KR, Meyer JG, Bennett EJ, Komives EA (2017) Site&#x2010;specific identification and quantitation of endogenous SUMO modifications under native conditions. Nat Commun 8: 1171</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5660086</ArticleId><ArticleId IdType="pubmed">29079793</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K, Weng SM, Haass C, Kretzschmar HA, Edbauer D et&#xa0;al (2013) Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico&#x2010;pathological correlations. Acta Neuropathol 126: 859&#x2013;879</Citation><ArticleIdList><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Frick P, Grasser FA, Gendron TF, Petrucelli L, Cashman NR, Edbauer D, Kremmer E, Prudlo J, Troost D et&#xa0;al (2015) Quantitative analysis and clinico&#x2010;pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol 130: 845&#x2013;861</Citation><ArticleIdList><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchenko ND, Hanel W, Li D, Becker K, Reich N, Moll UM (2010) Stress&#x2010;mediated nuclear stabilization of p53 is regulated by ubiquitination and importin&#x2010;alpha3 binding. Cell Death Differ 17: 255&#x2013;267</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419752</ArticleId><ArticleId IdType="pubmed">19927155</ArticleId></ArticleIdList></Reference><Reference><Citation>May S, Hornburg D, Schludi MH, Arzberger T, Rentzsch K, Schwenk BM, Grasser FA, Mori K, Kremmer E, Banzhaf&#x2010;Strathmann J et&#xa0;al (2014) C9orf72 FTLD/ALS&#x2010;associated Gly&#x2010;Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol 128: 485&#x2013;503</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159571</ArticleId><ArticleId IdType="pubmed">25120191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C et&#xa0;al (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide&#x2010;repeat proteins in FTLD/ALS. Science 339: 1335&#x2013;1338</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Myeku N, Clelland CL, Emrani S, Kukushkin NV, Yu WH, Goldberg AL, Duff KE (2016) Tau&#x2010;driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP&#x2010;PKA signaling. Nat Med 22: 46&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4787271</ArticleId><ArticleId IdType="pubmed">26692334</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et&#xa0;al (2006) Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L, Montrasio F, Pattamatta A, Tusi SK, Bardhi O, Meyer KD, Hayes L, Nakamura K, Banez&#x2010;Coronel M, Coyne A et&#xa0;al (2020) Antibody therapy targeting RAN proteins rescues C9 ALS/FTD phenotypes in C9orf72 mouse model. Neuron 105: 645&#x2013;662.e11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391607</ArticleId><ArticleId IdType="pubmed">31831332</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura AL, Zupunski V, Troakes C, Kathe C, Fratta P, Howell M, Gallo JM, Hortobagyi T, Shaw CE, Rogelj B (2010) Nuclear import impairment causes cytoplasmic trans&#x2010;activation response DNA&#x2010;binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain 133: 1763&#x2013;1771</Citation><ArticleIdList><ArticleId IdType="pubmed">20472655</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Masuda&#x2010;Suzukake M, Hosokawa M, Shimozawa A, Hirai S, Okado H, Hasegawa M (2018) C9ORF72 dipeptide repeat poly&#x2010;GA inclusions promote intracellular aggregation of phosphorylated TDP&#x2010;43. Hum Mol Genet 27: 2658&#x2013;2670</Citation><ArticleIdList><ArticleId IdType="pubmed">29750243</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier&#x2010;Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C et&#xa0;al (2011) Long pre&#x2010;mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP&#x2010;43. Nat Neurosci 14: 459&#x2013;468</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK (2019) Molecular mechanisms of TDP&#x2010;43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci 12: 25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon&#x2010;Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L et&#xa0;al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21&#x2010;linked ALS&#x2010;FTD. Neuron 72: 257&#x2013;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Jiang J, Garcia SD, Taylor AE, Schulte D, Ohkubo T, Schloffman CL, Maldonado M, Baughn M et&#xa0;al (2018) Sense&#x2010;encoded poly&#x2010;GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co&#x2010;localize with TDP&#x2010;43 in dendrites of repeat&#x2010;expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol 135: 459&#x2013;474</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, May S, Grasser FA, Rentzsch K, Kremmer E, Kupper C, Klopstock T; German Consortium for Frontotemporal Lobar Degeneration; Bavarian Brain Banking Alliance , Arzberger T et&#xa0;al (2015) Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol 130: 537&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4575390</ArticleId><ArticleId IdType="pubmed">26085200</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, Becker L, Garrett L, Gendron TF, Zhou Q, Schreiber F, Popper B, Dimou L, Strom TM, Winkelmann J et&#xa0;al (2017) Spinal poly&#x2010;GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol 134: 241&#x2013;254</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Chen HJ, Shaw CE (2015) TDP&#x2010;43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics 12: 352&#x2013;363</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Shcherbakova DM, Verkhusha VV (2013) Near&#x2010;infrared fluorescent proteins for multicolor in&#xa0;vivo imaging. Nat Methods 10: 751&#x2013;754</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3737237</ArticleId><ArticleId IdType="pubmed">23770755</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon DA, Stepto A, Au WH, Adachi Y, Diaper DC, Hall R, Rekhi A, Boudi A, Tziortzouda P, Lee YB et&#xa0;al (2018) A feedback loop between dipeptide&#x2010;repeat protein, TDP&#x2010;43 and karyopherin&#x2010;alpha mediates C9orf72&#x2010;related neurodegeneration. Brain 141: 2908&#x2013;2924</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6158706</ArticleId><ArticleId IdType="pubmed">30239641</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashiro Y, Urushitani M, Inoue H, Koike M, Uchiyama Y, Komatsu M, Tanaka K, Yamazaki M, Abe M, Misawa H et&#xa0;al (2012) Motor neuron&#x2010;specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J Biol Chem 287: 42984&#x2013;42994</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522293</ArticleId><ArticleId IdType="pubmed">23095749</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, Konig J, Hortobagyi T, Nishimura AL, Zupunski V et&#xa0;al (2011) Characterizing the RNA targets and position&#x2010;dependent splicing regulation by TDP&#x2010;43. Nat Neurosci 14: 452&#x2013;458</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JN, Trujillo A, Pribadi M, Phillips JJ, Gaus SE, Hixson JD et&#xa0;al (2016) Timing and significance of pathological features in C9orf72 expansion&#x2010;associated frontotemporal dementia. Brain 139: 3202&#x2013;3216</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5790143</ArticleId><ArticleId IdType="pubmed">27797809</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilchez D, Boyer L, Morantte I, Lutz M, Merkwirth C, Joyce D, Spencer B, Page L, Masliah E, Berggren WT et&#xa0;al (2012) Increased proteasome activity in human embryonic stem cells is regulated by PSMD11. Nature 489: 304&#x2013;308</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5215918</ArticleId><ArticleId IdType="pubmed">22972301</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagstaff KM, Rawlinson SM, Hearps AC, Jans DA (2011) An AlphaScreen(R)&#x2010;based assay for high&#x2010;throughput screening for specific inhibitors of nuclear import. J Biomol Screen 16: 192&#x2013;200</Citation><ArticleIdList><ArticleId IdType="pubmed">21297106</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, Tripathy K, Kwong LK, Trojanowski JQ, Lee VM (2015) Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP&#x2010;43. Acta Neuropathol 130: 643&#x2013;660</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, Krishnamurthy K, Markandaiah SS, Shi Y, Lin S, Shneider NA, Monaghan J, Pandey UB et&#xa0;al (2014) Antisense proline&#x2010;arginine RAN dipeptides linked to C9ORF72&#x2010;ALS/FTD form toxic nuclear aggregates that initiate in&#xa0;vitro and in&#xa0;vivo neuronal death. Neuron 84: 1213&#x2013;1225</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, Jensen BK, Wen X, Cai J, Kropf E, Iacovitti L, Pasinelli P, Trotti D (2016) Cell&#x2010;to&#x2010;cell transmission of dipeptide repeat proteins linked to C9orf72&#x2010;ALS/FTD. Cell Rep 17: 645&#x2013;652</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM (2008) Disturbance of nuclear and cytoplasmic TAR DNA&#x2010;binding protein (TDP&#x2010;43) induces disease&#x2010;like redistribution, sequestration, and aggregate formation. J Biol Chem 283: 13302&#x2013;13309</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin P, Guo X, Yang W, Yan S, Yang S, Zhao T, Sun Q, Liu Y, Li S, Li XJ (2019) Caspase&#x2010;4 mediates cytoplasmic accumulation of TDP&#x2010;43 in the primate brains. Acta Neuropathol 137: 919&#x2013;937</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531422</ArticleId><ArticleId IdType="pubmed">30810811</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, Lin WL, Tong J, Castanedes&#x2010;Casey M, Ash P et&#xa0;al (2009) Aberrant cleavage of TDP&#x2010;43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci USA 106: 7607&#x2013;7612</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, Daley EL, Miller SJ, Cunningham KM, Vidensky S et&#xa0;al (2015) The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525: 56&#x2013;61</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Gendron TF, Grima JC, Sasaguri H, Jansen&#x2010;West K, Xu YF, Katzman RB, Gass J, Murray ME, Shinohara M et&#xa0;al (2016) C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat Neurosci 19: 668&#x2013;677</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Lehmer C, Michaelsen M, Mori K, Alterauge D, Baumjohann D, Schludi MH, Greiling J, Farny D, Flatley A et&#xa0;al (2017) Antibodies inhibit transmission and aggregation of C9orf72 poly&#x2010;GA dipeptide repeat proteins. EMBO Mol Med 9: 687&#x2013;702</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5412769</ArticleId><ArticleId IdType="pubmed">28351931</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Mareljic N, Michaelsen M, Parhizkar S, Heindl S, Nuscher B, Farny D, Czuppa M, Schludi C, Graf A et&#xa0;al (2020) Active poly&#x2010;GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model. EMBO Mol Med 12: e10919</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7005532</ArticleId><ArticleId IdType="pubmed">31858749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Liu Y, Banez&#x2010;Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH et&#xa0;al (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci USA 110: E4968&#x2013;E4977</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>